INTERNATIONAL PATENT: NEURODAWN PHARMACEUTICAL CO., LTD., 南京宁丹新药技术股份有限公司 FILES APPLICATION FOR "USE OF 2-HYDROXY-4-(2-HYDROXY-3,5-DICHLOROBENZYL)AMINOBENZOIC ACID 2-CAMPHOL ESTER IN TREATMENT OF PSYCHIATRIC DISEASES"

Posted On: 2025-12-29

GENEVA, Dec. 29 -- NEURODAWN PHARMACEUTICAL CO., LTD. (L3244, 3rd Floor, Chuangye Building No. 1009 Tianyuan East Road, Jiangning DistrictNanjing, Jiangsu 211199), 南京宁丹新药技术股份有限公司 (中国江苏省南京市江宁区天元东路1009号创业大厦3层L3244) filed a patent application (PCT/CN2025/102376) for "USE OF 2-HYDROXY-4-(2-HYDROXY-3,5-DICHLOROBENZYL)AMINOBENZOIC ACID 2-CAMPHOL ESTER IN TREATMENT OF PSYCHIATRIC DISEASES" on Jun 20, 2025. With publication no. WO/2025/261487, the details related to the patent application was published on De...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: NEURODAWN PHARMACEUTICAL CO., LTD., 南京宁丹新药技术股份有限公司 FILES APPLICATION FOR "USE OF 2-HYDROXY-4-(2-HYDROXY-3,5-DICHLOROBENZYL)AMINOBENZOIC ACID 2-CAMPHOL ESTER IN TREATMENT OF PSYCHIATRIC DISEASES"